CPhI Announces Finalists for Pharma Awards
Winners for the 2013 CPhI Pharma Awards, which recognize pharmaceutical innovation, will be awarded on later today, Tuesday Oct. 22.
As CPhI Worldwide kicks off this week in Frankfurt, the finalists for the CPhI Pharma Awards have been released. The winners will be announced at a special awards ceremony at CPhI on Tuesday Oct. 22. CPhI is recognizing innovation in three categories: process development, formulation, and packaging.
Three finalists are up for the Best Innovation in Process Development. They include: API Corporation (Tokyo) for a practical synthesis of functionalized pharmaceuticals through carbon–hydrogen activation; Bachem (Bubendorf, Switzerland) for a chemical synthesis of interferon beta-1a; and Codexis (Redwood City, California) for green and scaleable biocatalytic oxidations.
Three finalists are competing for the Best Innovation in Formulation. They include: Bitop AG (Witten, Germany) for Ectoin, a proprietary ingredient derived from an amino acid found in extremophilic microorganisms and which has cell-protective properties that can be used in medical devices, life-science products, and cosmetics; Camurus (Lund, Switzerland) for FluidCrystal, a proprietary injection depot and related technology; and EmulTech BV (Eindhoven, the Netherlands) for its microfluidic platform and technology.
The three finalists for the Best Innovation in Packaging are: E-Pharma Trento (Trento, Italy), which specializes in niche oral delivery soluble forms, for a three-layer blister pack designed to protect fragile dosage forms such as orally disintegrating tablets; Doctor Pack India (Bangalore, India) for MAGIC CAP, which allows for sterile piercing and precise dosage for drops; and Neutroplast (Sobral Monte Agraço, Portugal) for a vaginal applicator.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
